Navigation Links
Rhesus Monkey IFN-Alpha from Cell Sciences

ProductsRhesus Monkey IFN-Alpha from Cell Sciences
Company Cell Sciences
Item Rhesus Monkey IFN-Alpha
Price $365.00
Description Recombinant Rhesus Monkey IFN-Alpha
Info Cell SciencesCell Sciences
480 Neponset Street
Building 12A
Canton, MA 02021
USA
Customer Service:
888 769-1246 (US and Canada)
781 828-0610

Fax Number:
781 828-0542

Web Site: http://www.cellsciences.com/
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. Rhesus Monkey IFN Alpha from PBL InterferonSource
2. StemSep Rhesus CD4+ T Cells, 2 mL Kit from StemCell Technologies, Inc.
3. StemSep Rhesus T Cell Purging, 2 mL Kit from StemCell Technologies, Inc.
4. Frozen Tissue Section Panel - Monkey (Rhesus) Normal Tissue, Multi-tissue I from BioChain
5. Rhesus Macaque IFN-alpha from R&D Systems
6. Rhesus Serum from Innovative Research
7. Monkey sICAM-1 ELISA Kit from Bender MedSystems
8. Monkey sE-selectin ELISA Kit from Bender MedSystems
9. Monkey sP-selectin ELISA Kit, Instant from Bender MedSystems
10. Monkey sP-selectin ELISA Kit from Bender MedSystems
11. Monkey sPECAM-1 ELISA Kit, Instant from Bender MedSystems
... Direct In Situ Apoptosis Detection ... situ by the direct TUNEL ... tagged with a directly labeled ... fluorescence staining for 40 samples ...
... BioGenex VISION Sytem is a highly ... with proprietary digital imaging and automation ... image acquisition, analysis, archving/retrieval and colored ... with the industry's fastest scanning and ...
... is used for second-dimension SDS-PAGE sample ... place in PROTEAN Plus cells. Bromophenol ... allow monitoring of electrophoresis runs. The ... in 1x Tris, glycine, SDS, and ...
... a low melting point agarose used for ... strips in place for most applications. Bromophenol ... monitoring of electrophoresis runs. The solution is ... in 1x Tris, glycine, SDS, and 0.003% ...
Biology Products:
(Date:12/13/2009)... associated with the health of the human lung. The ... 63 centres in Europe and Australia sheds new light ... new findings provide hope for better treatment for lung ... In the past it has been difficult to develop ... health of the lung are not completely understood. It,s ...
(Date:12/11/2009)... most school children understand that green plants photosynthesize, ... consider the profound global-scale effects that photosynthesis has ... light on the origins and evolution of photosynthesis ... University,s School of Life Sciences. , Oxygen, one ... as cyanobacteria and their descendants (including algae and ...
(Date:12/11/2009)... . , Montreal, December 11, 2009 ... prevents cancer. In the December 11 edition of the ... Universit de Montral and the Universit de Sherbrooke explain ... cancer-causing activity of cytokines, hormones that are culprits in ... and people exposed to asbestos. , "Excessive cytokine ...
Breaking Biology News(10 mins):New genes for lung disease discovered 2'Extreme' genes shed light on origins of photosynthesis 2'Extreme' genes shed light on origins of photosynthesis 3Scientists identify natural anti-cancer defenses 2LNA Based HIF 1 Alpha Inhibitor Shows Early Signs of Clinical Benefit 12470 1LNA Based HIF 1 Alpha Inhibitor Shows Early Signs of Clinical Benefit 12470 2LNA Based HIF 1 Alpha Inhibitor Shows Early Signs of Clinical Benefit 12470 3Accuray Incorporated to Present at Eighth Annual Needham Life Sciences Conference 47907 1Accuray Incorporated to Present at Eighth Annual Needham Life Sciences Conference 47907 2Strangers Cell Phone Ring May Thwart Your Thinking 47902 1Strangers Cell Phone Ring May Thwart Your Thinking 47902 2Strangers Cell Phone Ring May Thwart Your Thinking 47902 3
... 'superbug' evades many of the measures introduced to combat ... almost everywhere in hospital wards, according to new research ... the University of Bath have shown that MRSA infects ... polyphaga, which is ubiquitous in the environment and can ...
... discovered that a wide variety of different cancers actually share ... bits of genetic material called microRNA (miRNA) that target key ... provides more insight into miRNA as an emerging class of ... approaches in diagnosis and treatment. , The study appears ...
... have discovered that some type of protective system goes ... system is deficient. This discovery indicates a hidden safety ... of the immune system such as AIDS. The Mayo ... Baltimore, and is reported in the early online edition ...
Other Biology News:MRSA use amoeba to spread, new research shows 2Common molecular 'signature' identified in solid tumors 2Common molecular 'signature' identified in solid tumors 3Infant transplant patients resist infections that kill adult AIDS patients 2Infant transplant patients resist infections that kill adult AIDS patients 3
(Date:12/14/2009)... Dec. 14 Nektar Therapeutics (Nasdaq: ... been appointed to serve on its board of ... leader with over 35 years of experience in ... brings to Nektar extensive industry perspective at an ... W. Robin, President and CEO of Nektar and ...
(Date:12/11/2009)... -- Dendreon Corporation (Nasdaq: DNDN ) announced ... public offering have exercised in full their option ... stock at the public offering price of $24.75 ... increases the size of the offering to an ... Dendreon expects to receive net proceeds from the ...
(Date:12/11/2009)... ASA (OSE: ALGETA), the,cancer therapeutics company, announces ... the Tulane Cancer Center, New Orleans, has ... study of Alpharadin in men with,castration-resistant (also ... metastasized to the skeleton. , ... Prostate CAncer) study is a,double-blind, randomized, controlled ...
(Date:12/10/2009)... Dendreon Corporation (Nasdaq: DNDN ) announced today that ... shares of its common stock at a price to ... granted to the underwriters a 30-day option to purchase ... to cover overallotments, if any. The offering is ... customary closing conditions. ,, J. P. Morgan Securities Inc. ...
Breaking Biology Technology:Dennis Winger Joins Nektar Therapeutics' Board of Directors 2Dennis Winger Joins Nektar Therapeutics' Board of Directors 3Dendreon Announces Exercise of Option by Underwriters in its Common Stock Offering 2Dendreon Announces Exercise of Option by Underwriters in its Common Stock Offering 3Algeta Announces First US Patient Randomized in ALSYMPCA Phase III Study at Tulane Cancer Center, New Orleans 2Algeta Announces First US Patient Randomized in ALSYMPCA Phase III Study at Tulane Cancer Center, New Orleans 3Algeta Announces First US Patient Randomized in ALSYMPCA Phase III Study at Tulane Cancer Center, New Orleans 4Dendreon Announces Pricing of Common Stock Offering 2Dendreon Announces Pricing of Common Stock Offering 3